The March 10, 2015, article by Den et al, entitled “Genomic Classifier Identifies Men With Adverse Pathology After Radical Prostatectomy Who Benefit From Adjuvant Radiation Therapy” (J Clin Oncol 33:944-951, 2015), contained errors. In Figures 2A, 2B, 4A, and 4B, data in the first and third rows of the “No. at risk” tables below the figure parts were inadvertently transposed.
In Figure 2A, in the first row of the table, the number of patients at risk in the “CAPRA-S < 3” group was given as 79 at 0 years after radiotherapy (RT), 35 at 5 years after RT, and 16 at 10 years after RT, whereas it should have been 10 at 0 years after RT, 6 at 5 years after RT, and 0 at 10 years after RT. In the third row of the table, the number of patients at risk in the “CAPRA-S > 5” group was given as 10 at 0 years after RT, 6 at 5 years after RT, and 0 at 10 years after RT, whereas it should have been 79 at 0 years after RT, 35 at 5 years after RT, and 16 at 10 years after RT.
In Figure 2B, in the first row of the table, the number of patients at risk in the “GC < 0.4” group was given as 34 at 0 years after RT, 14 at 5 years after RT, and 5 at 10 years after RT, whereas it should have been 77 at 0 years after RT, 44 at 5 years after RT, and 11 at 10 years after RT. In the third row of the table, the number of patients at risk in the “GC > 0.6” group was given as 77 at 0 years after RT, 44 at 5 years after RT, and 11 at 10 years after RT, whereas it should have been 34 at 0 years after RT, 14 at 5 years after RT, and 5 at 10 years after RT.
In Figure 4A, in the first row of the table, the number of patients at risk in the “RT PSA < 0.1” group was given as 15 at 0 years after RT, 7 at 5 years after RT, and 3 at 10 years after RT, whereas it should have been 12 at 0 years after RT, 7 at 5 years after RT, and 2 at 10 years after RT. In the third row of the table, the number of patients at risk in the “RT PSA > 0.5” group was given as 12 at 0 years after RT, 7 at 5 years after RT, and 2 at 10 years after RT, whereas it should have been 15 at 0 years after RT, 7 at 5 years after RT, and 3 at 10 years after RT.
In Figure 4B, in the first row of the table, the number of patients at risk in the “RT PSA < 0.1” group was given as 43 at 0 years after RT, 18 at 5 years after RT, and 6 at 10 years after RT, whereas it should have been 20 at 0 years after RT, 10 at 5 years after RT, and 4 at 10 years after RT. In the third row of the table, the number of patients at risk in the “RT PSA > 0.5” group was given as 20 at 0 years after RT, 10 at 5 years after RT, and 4 at 10 years after RT, whereas it should have been 43 at 0 years after RT, 18 at 5 years after RT, and 6 at 10 years after RT.
The online version has been corrected in departure from the print. Journal of Clinical Oncology apologizes for the error.